Shree Ganesh Remedies Quarterly Results for Trading Insights

SGRL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹5 Cr
QSept 2025
Quarterly Results

Shree Ganesh Remedies Quarterly Results Key Highlights

  • Revenue of ₹31 Cr in Sept 2025 (+14.8% vs Mar 2025, -6.1% vs Sept 2024)
  • Net Profit of ₹5 Cr in Sept 2025 (-28.6% vs Mar 2025, -16.7% vs Sept 2024)
  • EBITDA of ₹10 Cr in Sept 2025 (-16.7% vs Mar 2025)
  • Operating Margin of 32.0% in Sept 2025 (-8.0pp vs Mar 2025)
  • Earnings Per Share of ₹3.86 in Sept 2025 (-24.8% vs Mar 2025)

Shree Ganesh Remedies Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 31 27 25 22 33 14.8% -6.1%
Net Profit (₹ Cr) 5 7 4 3 6 - -
EBITDA (₹ Cr) 10 12 8 7 12 - -
EPS (₹) 3.86 5.13 2.68 2.41 4.97 - -
Operating Margin (%) 32.0% 40.0% 30.0% 32.0% 35.0% - -

Shree Ganesh Remedies Share Price Trend Around Quarterly Results

Visualize Shree Ganesh Remedies's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Shree Ganesh Remedies

Additional stock information and data for SGRL

SGRL company profile
SGRL PE ratio trends
SGRL 52-week high low

Profitability Ratios

Profit Margin 16.1%
EBITDA Margin 32.3%
Operating Margin 32.0%
ROE (Annual) 13.8%

Balance Sheet Highlights

Total Assets ₹192 Cr
Total Equity ₹145 Cr
Current Assets ₹78 Cr
Current Liabilities ₹31 Cr

Cash Flow Analysis

Operating Cash Flow ₹31 Cr
Investing Cash Flow ₹-36 Cr
Financing Cash Flow ₹-1 Cr
Net Cash Flow ₹-6 Cr

Current Market Data

Current Price ₹420.05
Exchange BSE
Last Updated Mar 30, 2026

Revenue Trend (₹ Cr)

Dec 2025 22
Jun 2025 25
Mar 2025 27
Sept 2025 31

Net Profit Trend (₹ Cr)

Dec 2025 3
Jun 2025 4
Mar 2025 7
Sept 2025 5

Operating Margin Trend (%)

Dec 2025 32.0%
Jun 2025 30.0%
Mar 2025 40.0%
Sept 2025 32.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Shree Ganesh Remedies quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹430,344.72 Cr 1757.2 14,875 3,125 +10.8% - 21.0% 135.2
Divis Laboratories
Sept 2025 		₹159,214.78 Cr 5947.0 2,860 689 +7.1% - 24.1% 229.0
Torrent Pharmaceuti…
Sept 2025 		₹144,367.29 Cr 4220.2 3,219 591 +11.3% - 18.4% 240.6
Lupin
Sept 2025 		₹107,238.09 Cr 2313.9 6,921 1,485 +23.2% - 21.5% 71.5
Dr Reddys Laborator…
Sept 2025 		₹106,974.57 Cr 1254.9 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores